Elan Pharmaceuticals
16 articles about Elan Pharmaceuticals
-
Mainstay Medical Announces the Appointment of Matthew Onaitis as Chief Financial Officer
8/20/2018
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, announces the appointment of Matthew Onaitis as Chief Financial Officer, effective August 20, 2018.
-
BlackThorn Therapeutics Names George S. Golumbeski, Ph.D., to Board of Directors
6/12/2018
BlackThorn Therapeutics today announced the appointment of a key strategic executive to the company’s board of directors, George S. Golumbeski, Ph.D.
-
Elan Pharmaceuticals Lab Liquidation Auctions -- South San Francisco Closure; to be Hosted by BioSurplus on Its Secure Online Auction Platform
1/9/2013
-
Elan Pharmaceuticals Announces Webcast of Fourth Quarter and Full-Year 2011 Financial Results
1/26/2012
-
Elan Pharmaceuticals Pays Transition Therapeutics Inc. $9M in Amended Deal for Phase II Alzheimer Candidate; Transition Eligible for $11 Million More
12/27/2010
-
Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research
2/2/2010
-
Elan Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
2/13/2008
-
Elan Pharmaceuticals Selects Medidata Solutions, Inc. Rave(R) to Support Clinical Development Activities
12/17/2007
-
Elan Pharmaceuticals Joins GeneGo, Inc.'s MetaTox Consortium
11/27/2007
-
Elan Pharmaceuticals Licenses Software and Databases From GeneGo, Inc.
10/30/2007
-
Tripos Discovery Research Ltd., a Subsidiary of Commonwealth Biotechnologies, Inc., Signs Library Analysis Agreement with Elan Pharmaceuticals
8/9/2007
-
Alzheimer's Drug Discovery Foundation and Elan Pharmaceuticals Announce Winners of Second Annual Novel Discovery Award Program
3/1/2007
-
Is There A Second Act For Tysabri?
4/28/2005
-
Epilepsy Drug Linked To Birth Defects, Low IQ
3/22/2005
-
Tysabri Withdrawal Clouds Future For Recovering Elan
3/9/2005
-
Snails Give Speedy Pain Relief!
3/5/2004